Our Signature Service: Specialized Newsletters
IntellaTurn’s email newsletters deliver unbiased and timely business-critical information to smart, busy biopharma professionals.
We include a clear headline, summarize the main points, give context, and provide the option to “go deeper” and learn more.
We offer three subscription tiers:
IntellaTurn’s
Weekly Scoop
Our free newsletter with headlines impacting the biopharma industry at large
Weekly
Regulatory
TrendWatch
✨ NEW! ✨
IntellaTurn’s Weekly Scoop PLUS rapidly evolving FDA and HHS regulatory and policy topics
Weekly
A reduced rate is available for
small teams of up to 10 employees
Curated and
Therapy Area News
Regulatory TrendWatch PLUS curated headlines relevant to your company’s unique focus
Daily, weekly, or twice-monthly
Includes option for ad-hoc research services
Paid Newsletter FAQs
How is the news delivered?
Direct to your inbox, as a succinct e-newsletter digest.
The newsletter is designed with an engaging and dynamic format optimized for both desktop and mobile devices.
Is there a limit to the number of recipients?
No; distribution is to an unlimited number of recipients, including employees, consultants, and board members.
How often will my company receive the newsletter?
Regulatory TrendWatch is issued on a weekly basis.
Curated and Therapy Area News is available on a daily, weekly, or twice-monthly basis, depending on your company’s specific needs.
Will my company be able to access past newsletters?
A PDF archive hosted on a secure webpage is included with every Curated and Therapy Area News tiered subscription.
What about breaking news stories that occur in between publication dates?
For Curated and Therapy Area News tiered subscriptions, we will alert you ASAP with news flashes for pre-specified essential topics, such as competitor data releases, FDA guidances, and late-breaker conference abstracts.
How can I learn more about IntellaTurn’s other services?
Our support varies from single-scope projects to customized retainer agreements.
Email us to learn about how we can help your company turn information into intelligence.
Additional Services
FDA, HHS, CMS, CDC, and NIH policy trends and government analysis
EMA, ICH, CIOMS, WHO, and other global health authority headlines
Draft and final guidance alerts
Regulatory affairs, GMP, drug safety, pharmacovigilance, and quality assurance support
Scientific, medical, and epidemiology literature searches
Expert internet and specialized database searching
Just about any other research question you may have